Tilray Inc buy pangu
Start price
16.09.22
/
100%
€3.24
Target price
16.10.22
€20.00
Performance (%)
-1.10%
End price
17.10.22
€3.21
Summary
This prediction ended on 17.10.22 with a price of €3.21. With a performance of -1.10%, the BUY prediction by pangu finished with a loss. pangu has 100% into this predictionTilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tilray Inc | -14.105% | -14.105% | -78.620% |
| iShares Core DAX® | 1.280% | 1.320% | 13.605% |
| iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
| iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
| iShares S&P 500 | -0.662% | -1.884% | 23.684% |
According to pangu what are the pros and cons of Tilray Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High dividend yield expected
positive Cash Flow expected
Good rating
High Investments for future growth
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Strong uniques
Growths much faster than the competition
Sustainability is important
Very differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Comments by pangu for this prediction
In the thread Tilray Inc diskutieren
Kursziel gesetzt auf 20,0
In the thread Trading Tilray Inc
Die von pangu gewählte maximale Laufzeit wurde überschritten